Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - paroxetine hydrochloride, quantity: 22.2 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate; lactose; hyprolose; hypromellose; macrogol 8000; titanium dioxide - paroxetine is indicated for the treatment of major depression and is effective in preventing the relapse of depressive symptoms. paroxetine is also indicated for the treatment of obsessive compulsive disorder and is effective in preventing the relapse of ocd. paroxetine is also indicated for the treatment of panic disorder and for the prevention of relapse of panic disorder. paroxetine is also indicated for the treatment of social anxiety disorder/social phobia. paroxetine is also indicated for the treatment of generalised anxiety disorder. paroxetine is also indicated for the treatment of posttraumatic stress disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - paroxetine hydrochloride hemihydrate -

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - procyclidine hydrochloride - solution for injection - 5 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - procyclidine hydrochloride - solution for injection - 5 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - paroxetine hydrochloride 22.8mg equivalent to 20 mg paroxetine;   - film coated tablet - 20 mg - active: paroxetine hydrochloride 22.8mg equivalent to 20 mg paroxetine   excipient: calcium hydrogen phosphate dihydrate magnesium stearate opadry white ys-1-7003 sodium starch glycolate - aropax is indicated for the treatment of major depressive disorder (mdd). aropax is indicated for the prevention of relapse and also recurrence of further depressive episodes.

India - English - Central Drugs Standard Control Organization

gsk - procyclidine hcl. - tab - 2.5 mg - 10

India - English - Central Drugs Standard Control Organization

gsk - procyclidine hcl. - tab - 5 mg - 10

Malta - English - Medicines Authority

p & d pharmaceuticals limited - procyclidine hydrochloride 10 mg/2ml - solution for injection

Canada - English - Health Canada

glaxosmithkline inc - procyclidine hydrochloride - elixir - 2.5mg - procyclidine hydrochloride 2.5mg - anticholinergic agents

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - procyclidine hydrochloride - solution for injection - procyclidine hydrochloride 5 mg/ml - anti-parkinson drugs